Syneos Health appoints Michael Brooks as Chief Development OfficerSyneos Health has appointed Michael Brooks as its new chief development officer. In this newly created role, Brooks Share XSyneos Health appoints Michael Brooks as Chief Development Officerhttps://pharmaphorum.com/news/syneos-health-appoints-michael-brooks-as-chief-development-officer/
GSK names McNamara as CEO of consumer health spinoutGlaxoSmithKline has said that Brian McNamara – currently head of its three-year-old consumer health joint venture with Pfizer Share XGSK names McNamara as CEO of consumer health spinouthttps://pharmaphorum.com/news/gsk-names-mcnamara-as-ceo-of-consumer-health-spinout/
Biogen bites back at critics of Aduhelm after drug’s slow startBiogen has reported $2m in sales for newly-launched Alzheimer’s therapy Aduhelm that came in below its expectations, prompting Share XBiogen bites back at critics of Aduhelm after drug’s slow starthttps://pharmaphorum.com/news/biogen-bites-back-at-critics-of-aduhelm-after-drugs-slow-start/
Ogilvy Health promotes Rebecca Carter to Head of Social MediaOgilvy Health UK has promoted Rebecca Carter to the newly created role of Head of Social Media. Carter Share XOgilvy Health promotes Rebecca Carter to Head of Social Mediahttps://pharmaphorum.com/sales-marketing/ogilvy-health-promotes-rebecca-carter-to-head-of-social-media/
Is J&J nearing the end of its opioid liability hangover?Johnson & Johnson and the ‘big three’ US pharma wholesalers are on the brink of a $26 billion Share XIs J&J nearing the end of its opioid liability hangover?https://pharmaphorum.com/news/is-jj-nearing-the-end-of-its-opioid-liability-hangover/
UK comms agency Fishawack Health restructures creative teamFishawack Health has announced a restructuring of its creative team to expand client support across global markets. The Share XUK comms agency Fishawack Health restructures creative teamhttps://pharmaphorum.com/news/fishawack-health-restructures-creative-team/
Healthware Group appoints Giovanni Loria as chief financial officerGiovanni Loria has joined global digital health innovation organisation Healthware Group as its new chief financial officer. He Share XHealthware Group appoints Giovanni Loria as chief financial officerhttps://pharmaphorum.com/news/healthware-group-appoints-giovanni-loria-as-chief-financial-officer/
UK fines drugmakers record £260m for price gouging NHSThe UK’s competition authority has issued its largest ever fine of more than £260 million ($360 million) to Share XUK fines drugmakers record £260m for price gouging NHShttps://pharmaphorum.com/news/uk-fines-drugmakers-record-260m-for-price-gouging-nhs/
Final hurdle falls as UK backs AZ’s $39bn takeover of AlexionThe UK’s competition regulator has approved AstraZeneca’s $39 billion acquisition of US-based drugmaker Alexion, without opting for a Share XFinal hurdle falls as UK backs AZ’s $39bn takeover of Alexionhttps://pharmaphorum.com/news/final-hurdle-falls-as-uk-backs-azs-39bn-takeover-of-alexion/
